Patent ID: 7064118
Filing Date: 2006-06-20
Classification: A61P,C07D

Abstract:
1. The dimeric diazacycloalkane represented by Formula II, III, or IV any of its enantiomers or any mixture thereof, an N oxide thereof, a pharmaceutically acceptable salt thereof, in a labelled or un-labelled form, wherein, n is 1; and m is 2; and R represents hydrogen, an alkyl group, a cycloalkyl group, a cycloalkylalkyl group, or an alkenyl group, or, when R is shown with two valences, R represents an alkylene group, a cycloalkylene group, a cycloalkylalkylene group, or an alkenylene group; and R “—R—B—R—” in Formula II represents a single bond bridge or a bridging group of the formula “—R—R—” or a bridging group of the formula “—R—”; or “—R—B—R “—R—B—R “—R—B—R—” in Formula IV represents a single bond bridge or a bridging group of the formula “—R B represents a single bond bridge or a bridging element of the formula “—ALK—”, “—ALK—X—ALK—”, “—X—ALK—X—”, “—PHE—”, “—X—PHE—X—”, or “—ALK—PHE—ALK—”; wherein “ALK” represents a single bond bridge or alkylene, alkenylene, or alkynylene; and “PHE” represents a phenylene group; and X represents O, S, NH, N-alkyl, or Se.